National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine
biologics; psoriasis; psoriatic arthritis; teledermatology; telemedicine; topical therapy
Telemedicine emerged as an alternative care delivery system used to offer effective long-term management to patients with chronic, inflammatory conditions such as psoriatic disease. Teledermatology can provide reliable clinical information through thorough history-taking and virtual evaluations that include patient-provided images and disease activity assessment tools that may help accurately diagnose and manage patients with psoriasis. The integration of validated screening tools for psoriatic arthritis and effective teledermatology practices may improve access to specialists, thus avoiding preventable delays in the diagnosis and treatment of patients with psoriatic arthritis. Although the provision of telehealthcare should not completely replace high quality, in-person dermatologic or rheumatologic visits, the convenience and collaborative nature of teledermatology may lead to expanded access and expedited care in the appropriate setting, whether it be in a virtual or in-person visit.
Pelet Del Toro, Natalia; Yahia, Rayan; Feldman, Steven R.; Van Voorhees, Abby; Green, Lawrence; Schwartzman, Sergio; Siegel, Evan; Cordoro, Kelly M.; Desai, Seemal R.; Kircik, Leon; Liao, Wilson; Hawkes, Jason E.; Weinberg, Jeffrey; Koo, John; Wallace, Elizabeth Brezinski; Howard, Leah M.; Armstrong, April; and Han, George, "National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine" (2023). GW Authored Works. Paper 3493.